Zurueck zur Suche

Reporte zur Charge U010533

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

52Reporte angezeigt
0Todesfaelle
4Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MI 6 MO 4 VA 4 KS 3 NC 3 FL 3 GA 3 KY 3 ID 2 TX 2 OK 2 IL 2

VAERS 2395193

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

moderat
Staat
VA
Alter
44,0
Geschlecht
F
Eingang
28.07.2022
Impfdatum
28.07.2022
Beginn
28.07.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Abdominal pain upper Dizziness Dyspnoea Feeling hot Flushing

Symptomtext

HOT FLUSHING OF FACE, STOMACH PAIN, LIGHT HEADEDNESS, SHORTNESS OF BREATH

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
COCHLEAR IMPLANT
Vorgeschichte
HIGH BLOOD PRESSURE, ACID REFLUX
Andere Medikamente
PREDNISONE, TRELEGY ELLIPTA, VITAMIN D2 50,000U, PRIMIDONE, MONTELUKAST, HYDROXYCHLOROQUINE, ESOMEPRAZOLE, OXCARBAZEPINE, AND LOSARTAN.
Allergien
VALPROIC ACID, HYDANTOINS
Vorherige Impfungen
-

VAERS 2379342

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge u010533

moderat
Staat
OR
Alter
68,0
Geschlecht
F
Eingang
22.07.2022
Impfdatum
19.07.2022
Beginn
20.07.2022
Tage bis Beginn
1,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Induration Mobility decreased Peripheral swelling Skin warm

Symptomtext

Pt's arm got swollen, hot to touch, and had hardened tissue. It was also difficult to lift her arm.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
Pt rec'd antibiotic shot at the Urgent Care. 7/20/22, antibiotic Cephalexin 500mg was started orally 7/21/22 Arm was not improving so pt went to the ER where care was given.
Aktuelle Erkrankungen
n/a
Vorgeschichte
hypertension
Andere Medikamente
n/a
Allergien
n/a
Vorherige Impfungen
-

VAERS 2131472

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

moderat
Staat
MD
Alter
62,0
Geschlecht
M
Eingang
22.02.2022
Impfdatum
29.11.2021
Beginn
29.11.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Hypoaesthesia Pain in extremity Paraesthesia

Symptomtext

Pt received 2 IMZ's on the left arm 1 inch apart on 11/29/21. Pt started to feel the pain, numbness and tingling on the left arm that radiated to the left shoulder. On 2/21/22 when pt came back for second dose of Shingrix and reported that the numbness travel down the the elbow/mid arm area overtime. Now the numbness is by the fingers only.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
not known
Vorgeschichte
none
Andere Medikamente
not known
Allergien
NKA
Vorherige Impfungen
-

VAERS 2014604

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

moderat
Staat
NC
Alter
65,0
Geschlecht
F
Eingang
07.01.2022
Impfdatum
04.01.2022
Beginn
05.01.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injected limb mobility decreased Injection site pain Injection site swelling

Symptomtext

65yr old patient presented on 1/4/22 for well visit. Patient was ordered Pneumococcal polysaccharide vaccine 23-valent greater than or equal to 2yo SQ/IM (PNEUMOVAX-23) to be administered during visit. RN administered Pneumococcal Polysaccharide 23-Valent (Pneumovax-23) LOT # U010533 IM in patient's left deltoid. On 1/5, patient contacted office to report should pain and swelling near injection site. Patient indicated limited range of motion. Patient endorsed taking acetaminophen without improvement. Patient felt may have "bursitis" and needs steroid injection. Patient scheduled ortho sports medicine appointment (1/11/22) however, later canceled as symptoms improved.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injected limb mobility decreased
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1940174

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge u010533

moderat
Staat
FL
Alter
67,0
Geschlecht
F
Eingang
10.12.2021
Impfdatum
08.12.2021
Beginn
08.12.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Burning sensation Injection site erythema Injection site pain Injection site paraesthesia

Symptomtext

Patient described redness and pain along with tingling starting from injection site, which then spread down to elbow and shoulder blade. It initially started at about 8PM on the day of vaccination and then continued, reported after 2 days and was still present. Patient tried taking both benadryl 25 mg and naproxen 220 mg neither provided relief from burning or pain. Informed patient to continue trying benadryl as tolerated and tylenol or ibuprofen for pain.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site paraesthesia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1937033

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge u010533

moderat
Staat
GA
Alter
68,0
Geschlecht
F
Eingang
09.12.2021
Impfdatum
07.12.2021
Beginn
07.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Hypersensitivity Injected limb mobility decreased Injection site pain Product administered at inappropriate site

Symptomtext

Patient received pneumovax 23 vaccine on 12/7/21. Patient called pharmacy on 12/9/21 and stated she began feeling pain at injection site shortly after vaccine adminstration and went to emergency room later that night due to extreme pain. Patient stated the emegency room physican told her she was not having an allergic reaction and the pain was due to vaccine administration too high in the arm. Patient said she was given pain medication at the emergency room but is still having pain and cannot move her arm 2 days later. Patient will follow up with primary care physician if pain continues.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injected limb mobility decreased
Hospital-Tage
-
Labordaten
Emergency room visit 12/7/21
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1912970

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

moderat
Staat
FL
Alter
51,0
Geschlecht
M
Eingang
01.12.2021
Impfdatum
28.11.2021
Beginn
28.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extensive swelling of vaccinated limb Injection site erythema Injection site swelling Mobility decreased Nausea Pain in extremity Pyrexia

Symptomtext

Extreme swelling, redness of entire deltoid and bicep area to 1/2" above elbow of left arm; Nausea; Fever (100-104.1); Loss of motion; Excessive pain over entire bicep area.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Primary Immune Deficiency; Hashimoto; ITP; Psoriasis / Psoriatic Arthritis
Andere Medikamente
Adderall 10 mg OD; Levothyroxine .125 mg OD; Eliquis 5mg BID; Hizentra 10g/50 ml vial - 100ml once weekly
Allergien
-
Vorherige Impfungen
Tetanus - 2 years old, Unknown brand

VAERS 1815671

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

moderat
Staat
WA
Alter
77,0
Geschlecht
F
Eingang
25.10.2021
Impfdatum
12.10.2021
Beginn
13.10.2021
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Bursitis Injected limb mobility decreased Injection site pain Ultrasound joint X-ray abnormal

Symptomtext

The next day (10/13/21) reported significant left upper arm/shoulder pain, limited range of motion. Seen in clinic 10/15/21, supportive care advised over next few days. Due to persistence, imaging obtained. Xray 10/19/21 without bony abnormalities. Ultrasound 10/20/21 showed "IMPRESSION: Left shoulder fluid collection suspicious for bursitis. No evidence of hemorrhage or infection at this time." Referred to physical therapy and steroid taper prescribed(10/22/21).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injected limb mobility decreased
Hospital-Tage
-
Labordaten
See above, treatment for this condition is ongoing and being assessed regularly
Aktuelle Erkrankungen
Had left hip intertrochanteric femur fracture s/p surgical repair in early 3/2021.
Vorgeschichte
Osteoporosis, hypothyroidism, protein calorie malnutrition (BMI 17.6), depression, peripheral vascular disease
Andere Medikamente
Spironolactone, rosuvastatin, potassium, levothyroxine, minocycline, fluocinonide, co Q10, multivitamin, B complex vitamin, calcium carbonate-vitamin D, magnesium, aspirin, denosumab, bimatoprost, timolol
Allergien
atorvastatin, alendronate, brimonidine, hydrochlorothiazide, mirtazapine, simvastatin
Vorherige Impfungen
-

VAERS 1777587

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

moderat
Staat
GA
Alter
65,0
Geschlecht
F
Eingang
11.10.2021
Impfdatum
09.10.2021
Beginn
10.10.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Paraesthesia Peripheral swelling

Symptomtext

Patient has swelling in the arm, and a tingling sensation down her arm.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
Tramadol
Vorherige Impfungen
-

VAERS 2401449

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

mild
Staat
-
Alter
80,0
Geschlecht
F
Eingang
04.08.2022
Impfdatum
03.08.2022
Beginn
04.08.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Injection site erythema Injection site swelling

Symptomtext

pt called and reported swelling at the injection site and redness that spread down to the elbow

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2379410

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge u010533

mild
Staat
KY
Alter
66,0
Geschlecht
F
Eingang
22.07.2022
Impfdatum
17.07.2022
Beginn
18.07.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Joint range of motion decreased Pain

Symptomtext

Patient states that she is having painful ROM moving her arm away from her body

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NO
Vorgeschichte
Hypothyroidism, SVT
Andere Medikamente
-
Allergien
PCN
Vorherige Impfungen
-

VAERS 2275877

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

mild
Staat
-
Alter
69,0
Geschlecht
F
Eingang
13.05.2022
Impfdatum
09.05.2022
Beginn
10.05.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Vaccination site erythema Vaccination site pain Vaccination site warmth

Symptomtext

Localized vaccine reaction (localized redness, warmth, pain)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Vaccination site pain
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
None
Vorgeschichte
Seizure disorder, migraines, hyperlipidemia, hypertension, allergic rhinitis, osteoporosis
Andere Medikamente
Aspirin, vitamin D, vitamin B12, Depakote, ezetimibe, Allegra, Flonase, Boniva, lisinopril, magnesium oxide, Fish oil, Dilantin, Vitamin C
Allergien
Mucinex (rash); Pravastatin (rash).
Vorherige Impfungen
-

VAERS 2264799

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

mild
Staat
IL
Alter
75,0
Geschlecht
M
Eingang
05.05.2022
Impfdatum
02.05.2022
Beginn
02.05.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Dizziness Gait disturbance Immediate post-injection reaction Nightmare Pain in extremity Restlessness Somnolence

Symptomtext

Patient's right arm was immediately very sore (Pneumovax 23). He stated that night he was very restless and had constant nightmares. He woke up shivering, had trouble walking, unsteady and dizzy. His wife prevented a near fall from the dizziness when he was getting up. He stated today 5/5/2022 he is still a bit groggy and unsteady, but is feeling much better.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
None.
Aktuelle Erkrankungen
Essential tremor, heart disease
Vorgeschichte
Cancer, COPD, essential tremor, heart disease
Andere Medikamente
Tamsulosin, Oxybutynin, Duoneb, Furosemide, Pregabalin, Pantoprazole, Clopidogrel, Metoprolol, Atorvastatin, Zolpidem, Advair, Alprazolam, Colchicine
Allergien
Gabapentin
Vorherige Impfungen
-

VAERS 2225941

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

mild
Staat
LA
Alter
66,0
Geschlecht
F
Eingang
11.04.2022
Impfdatum
22.10.2021
Beginn
03.11.2021
Tage bis Beginn
12,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Anal sphincter atony Back pain CSF protein increased Gait inability Hypoaesthesia Injection site pain Intervertebral disc disorder Lumbar puncture abnormal Magnetic resonance imaging spinal normal Muscular weakness Sensory loss Urinary incontinence

Symptomtext

patient states she had arm pain at the site of injection that worsened throughout the week. went to ED on 11/3/2022 for back pain and bilateral leg weakness and numbness to the point of not being able to walk that started the day before. had associated loss of bladder control. in the ED pt had decreased anal sphincter tone and saddle anesthesia and was admitted to the hospital.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Back pain
Hospital-Tage
17,0
Labordaten
mri on 11/3/2021 showed stable lumbar disc disease lumbar puncture on 11/4/2021 showed high protein
Aktuelle Erkrankungen
none that was reported
Vorgeschichte
HTN, HLD, Temporal Arteritis, osteopenia,
Andere Medikamente
-
Allergien
Penicillins and Sulfa
Vorherige Impfungen
-

VAERS 2076628

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

mild
Staat
ID
Alter
26,0
Geschlecht
M
Eingang
31.01.2022
Impfdatum
28.01.2022
Beginn
29.01.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Erythema Injection site erythema

Symptomtext

Redness around area of injection that went from site of injection down to elbow

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2073091

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

mild
Staat
-
Alter
65,0
Geschlecht
F
Eingang
28.01.2022
Impfdatum
26.01.2022
Beginn
27.01.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Headache Injection site cellulitis Pain in extremity Pyrexia

Symptomtext

24 hours after administration of administration of TDAP and pneumovax, patient developed fever, headache, and right arm pain. Seen 1/28 and diagnosed with cellulitis to right arm at administration site.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
No tests ran, clinical diagnosis
Aktuelle Erkrankungen
-
Vorgeschichte
Chronic Small Cell Lymphoma Hypothyroid
Andere Medikamente
Levothyroxine
Allergien
-
Vorherige Impfungen
-

VAERS 2032328

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

mild
Staat
KY
Alter
53,0
Geschlecht
F
Eingang
13.01.2022
Impfdatum
13.12.2021
Beginn
13.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site swelling

Symptomtext

PATIENT STATED HER ARM STARTED SWEELING FROM INJECTION SITE TO ELBOW. PATIENT WAS IN CONTACT WITH PHYSCIAN AS WELL AND WAS PUT ON 2 ANTIBIOTICS PER PATIENT AND WAS TOLD TO MONITOR AND BE SEEN IF SWEELING DID NOT RESOLVE.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site swelling
Hospital-Tage
-
Labordaten
GIVING PRESCRIPTION ANTIBIOTICS (2) PER PATIENT AND WAS TOLD TO BE SEEN IF SWEELING DID NOT RESOLVE.
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1917281

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge u010533

mild
Staat
TX
Alter
64,0
Geschlecht
F
Eingang
02.12.2021
Impfdatum
30.11.2021
Beginn
30.11.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site cellulitis Injection site erythema Injection site pain Injection site swelling

Symptomtext

patient received flucelvax and pneumovax administered in the Left deltoid) around 1-2 pm and started to develop swelling, redness and pain in the left arm extending from underarm to the elbow. The swelling got bigger and redder overnight but started to resolve gradually the next day and following day. She walked into the pharmacy on 12/2/21 and expressed concern about the swelling which is still red and swollen but mildly. She was advised to consult with an MD due to symptoms looking similar to cellulitis. patient consulted with her PCP who diagnosed her with cellulitis and prescribed her Cephalexin and advised to use Ibuprofen and heat pads to resolve the swelling.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site cellulitis
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
diabetes, hypertension, heart burn,
Andere Medikamente
glipizide er 5 mg, pantoprazole 40 mg, triamcinolone 0.1% cream, lisinopril/hydrochlorthiazide 20/12.5 , flonase nasal spray
Allergien
none
Vorherige Impfungen
-

VAERS 1868525

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

mild
Staat
FL
Alter
66,0
Geschlecht
F
Eingang
14.11.2021
Impfdatum
04.11.2021
Beginn
04.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Myalgia Pain in extremity Sleep disorder

Symptomtext

The night the vaccine was administered (11/04/21) her bicep muscle and deltoid muscle hurt. She was unable to sleep due to the pain. The bicep pain is reoccurring and still felt today (11/14/21). The next day(11/05/21) the side of the deltoid muscle began to hurt and the deltoid muscle continued to hurt. However these two pain sites, the side of the deltoid muscle and the deltoid muscle pain resolved over time. The patient is still currently feeling pain and strain in her bicep muscle of the right arm. Advised patient to seek medical attention with her provider in which she has not sought out yet.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myalgia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1844319

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

mild
Staat
MI
Alter
71,0
Geschlecht
M
Eingang
04.11.2021
Impfdatum
04.11.2021
Beginn
04.11.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site swelling

Symptomtext

The patient came in around 11:30 am for vaccine administration of flu and pneumonia. The pneumonia was administered intramuscularly in the left deltoid. The patient was wearing a shirt he bunched up with his other hand and held up for vaccine adminstration. He returned at 7:15 pm to show that under the vaccine adminstration site on the left deltoid his arm was swollen and red. I recommended he ice the area and offered to contact his primary care physician in the morning to let the Dr know of his reaction to the vaccine. I informed the patient that his reaction would be reported to vaers.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1843329

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge u010533

mild
Staat
MO
Alter
65,0
Geschlecht
F
Eingang
04.11.2021
Impfdatum
02.11.2021
Beginn
03.11.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash macular

Symptomtext

Pt called 11/4 to state she had 2 spots on arm that received pneumovax 2 days ago. 1 is good sized (3 in a row) and 1 smaller. RPh advised watch and wait as we are just 2 days out. Shared that pt can use cold compress as well as otc pain meds. If area increases in size, streaks, etc. please call back so we can further investigate.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash macular
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
none
Vorherige Impfungen
-

VAERS 1834251

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

mild
Staat
RI
Alter
70,0
Geschlecht
F
Eingang
01.11.2021
Impfdatum
28.10.2021
Beginn
28.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Administration site swelling Administration site warmth Blood culture negative Hypoaesthesia Injection site erythema Injection site mass Injection site pain Pain Pyrexia

Symptomtext

The evening of the vaccine patient's arm got very red, hot, and swollen just below administration site. The next morning the swelling was very pronounce all the way down to the elbow and she was in excrutiating pain and her fingers were numb. We advised her to go to urgent care. They gave her IV dose of antibiotic and a prescription for cephalexin. Patient took 4 doses of cephalexin but swelling, redness got worse and she developed a fever. She went to hospital ER and was admitted. Was given IV antibiotics for 3 days and discharged on Augmentin. Still a lump in arm with some redness, but not near as bad, swelling and arm is warm to touch and still a little sore.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
3,0
Labordaten
On 10/30/21 blood cultures were performed but were negative so no sepsis.
Aktuelle Erkrankungen
None,
Vorgeschichte
None
Andere Medikamente
None........had a flu shot the week prior in same arm
Allergien
None
Vorherige Impfungen
-

VAERS 1813552

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

mild
Staat
WV
Alter
84,0
Geschlecht
F
Eingang
23.10.2021
Impfdatum
23.10.2021
Beginn
23.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site discolouration Injection site rash Injection site swelling Rash erythematous

Symptomtext

Patient called having swelling, red rash down to her elbow and blue discoloration

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site discolouration
Hospital-Tage
-
Labordaten
Referred her to pcp, er, or urgent care
Aktuelle Erkrankungen
N/A
Vorgeschichte
hypertension, peptic ulcer disease
Andere Medikamente
Toprol XL 100mg, benaz/hctz 20/25 mg, kcl 10 meq, trazodone 50 mg, protonix 40 mg, simvastatin 40 mg, Eliquis 5 mg
Allergien
Sulfa, Pennicillin
Vorherige Impfungen
-

VAERS 1794407

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

mild
Staat
GA
Alter
-
Geschlecht
F
Eingang
18.10.2021
Impfdatum
01.09.2020
Beginn
01.10.2021
Tage bis Beginn
395,0
Dosis
2
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Incorrect dose administered Pain in extremity Peripheral swelling

Symptomtext

her arm started to hurt and swell up; her arm started to hurt and swell up/ it looks like a bum wound that extends all the way to her elbow; accidently received the vaccine again; the injection site was swollen and red with bumps; redness with her arm; the injection site was swollen and red with bumps; the injection site was swollen and red with bumps; This spontaneous report was received from a pharmacist and a 63 years old female patient referring to the patient herself. Concomitant therapies included blood pressure medication, lifitegrast (XIIDRA) and covid-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE). The patient had seasonal allergies. Information about medical history was not provided. On an unknown date in September 2020 (also reported as about a year ago), the patient was initially vaccinated with the first dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (anatomical location: right arm, route reported as injection; strength, dose, lot# and expiration date were not reported) for prophylaxis, with no adverse effects to report. On 05-OCT-2021, the patient was accidently vaccinated with the second dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (0.5 ml, anatomical location: right arm, route reported as injection, lot # U010533, expiration date 29-OCT-2022; strength and frequency were not reported) for prophylaxis again despite not needing the revaccination (incorrect dose administered), a few hours after she received the second dose that her arm started to hurt and swell up. The patient mentioned that over the next few days she was having lots of pain, swelling, and redness with her arm. She mentioned that it was swollen by an inch thick, almost goes 3 quarters around the circumference of her arm, and had a distinct line around it. She mentioned it looked like a bum wound that extended all the way to her elbow. The patient did not seek medical attention but received paracetamol (TYLENOL) and paracetamol (ADVIL) as treatment. The outcome of all events except the event of incorrect dose administered was not resolved. The causality between all events except the event of incorrect dose administered and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was not provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Seasonal allergy
Vorgeschichte
-
Andere Medikamente
XIIDRA; MODERNA COVID-19 VACCINE
Allergien
-
Vorherige Impfungen
-

VAERS 1788523

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

mild
Staat
VA
Alter
82,0
Geschlecht
F
Eingang
15.10.2021
Impfdatum
14.10.2021
Beginn
14.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pruritus Injection site swelling Injection site warmth

Symptomtext

Patient she has swelling and redness down the right arm to her elbow. Patient states the arm is warm to the touch and itching. Patient will take benadryl and speak with doctor if symptoms worsen.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1779152

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge u010533

mild
Staat
VA
Alter
71,0
Geschlecht
M
Eingang
12.10.2021
Impfdatum
11.10.2021
Beginn
12.10.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema

Symptomtext

Pt got redness at the site of injection

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1778753

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

mild
Staat
KY
Alter
36,0
Geschlecht
M
Eingang
12.10.2021
Impfdatum
07.10.2021
Beginn
08.10.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Cellulitis Injection site cellulitis Pain Pyrexia

Symptomtext

Cellulitis, fever, body aches- admitted to Health center 10/9 or 10/10. getting IV antibiotics.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site cellulitis
Hospital-Tage
-
Labordaten
Admission to hospital r/t cellulitis at injection site
Aktuelle Erkrankungen
constipation
Vorgeschichte
diabetes type 2, HTN, hyperlipidemia, hx of stroke, covid Dec 2020
Andere Medikamente
losartan, rosuvastatin, trulicity, amlodipine, metformin, hydrochlorothiazide, ergocalciferol, cetirizine, fiber, vitamin C, apple cider vinegar, aspirin
Allergien
atorvastatin- myalgias, dehydration
Vorherige Impfungen
-

VAERS 1776921

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge u010533

mild
Staat
VA
Alter
66,0
Geschlecht
F
Eingang
11.10.2021
Impfdatum
08.10.2021
Beginn
08.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Injection site rash Malaise Pyrexia

Symptomtext

Pt got fever of 102 and felt like she had covid so she went to urgent care. They gave her medication and steroid. She is feeling better now, but she has a rash at the site of injection

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
She had a fever of 102 the night getting the vaccine and felt like she had covid so she went to an urgent care center. They gave her medication for the fever and also steroid. She is now better, but has a rash at the site of injection.
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1771992

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

mild
Staat
MI
Alter
70,0
Geschlecht
F
Eingang
08.10.2021
Impfdatum
28.09.2021
Beginn
29.09.2021
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pain in extremity Tenderness

Symptomtext

Patient reports feeling ongoing severe pain and tenderness in left arm from 9-29-21. Has been 10 days after the vaccine was given.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Asthma
Andere Medikamente
-
Allergien
none
Vorherige Impfungen
-

VAERS 1759745

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge u010533

mild
Staat
NJ
Alter
85,0
Geschlecht
F
Eingang
04.10.2021
Impfdatum
02.10.2021
Beginn
03.10.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site bruising Injection site erythema Injection site swelling Injection site warmth

Symptomtext

no issues immediately following vaccinations, next morning wokeup with redness at injection site and down arm to about her elbow, black and blue at injection site. was red and warm to the touch but not painful. patient iced arm and took tylenol, by the following morning (monday) the swelling went down alot but the black and blue spot at injection site remained

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site bruising
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
crestor,irbesartan,metformin
Allergien
none
Vorherige Impfungen
-

VAERS 2566943

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

gering
Staat
MO
Alter
-
Geschlecht
U
Eingang
17.02.2023
Impfdatum
24.01.2023
Beginn
24.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE details or PQC.; PNEUMOVAX 23 was inadvertently administered after it's expiration date; This spontaneous report as received from a licensed practical nurse, referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent condition and concomitant medication was not provided. On 24-JAN-2023, the patient was inadvertently vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) syringe (lot # U010533 with expiration date: 29-OCT-2022; 0.5 milliliter, strength and route were unknown) for prophylaxis (expired product administered). No symptomatic side effects reported during time of report. No additional adverse event (AE) details or product quality complaints (PQC).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2566943

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

gering
Staat
MO
Alter
-
Geschlecht
U
Eingang
17.02.2023
Impfdatum
24.01.2023
Beginn
24.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE details or PQC.; PNEUMOVAX 23 was inadvertently administered after it's expiration date; This spontaneous report as received from a licensed practical nurse, referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent condition and concomitant medication was not provided. On 24-JAN-2023, the patient was inadvertently vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) syringe (lot # U010533 with expiration date: 29-OCT-2022; 0.5 milliliter, strength and route were unknown) for prophylaxis (expired product administered). No symptomatic side effects reported during time of report. No additional adverse event (AE) details or product quality complaints (PQC).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2575590

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge u010533

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
04.02.2023
Impfdatum
24.01.2023
Beginn
24.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AEs were reported; Expired PNEUMOVAX 23 was administered to a patient.; This spontaneous report was received from a pharmacist and refers to a patient of an unknown age. The patient's medical history, concurrent conditions, concomitant therapies and previous drugs reactions or allergies were not reported. On 24-JAN-2023, the patient was vaccinated with an expired pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) lot #U010533, expiration date: 29-OCT-2022, administered for prophylaxis (strength, and route of administration were not provided) (Expired product administered). No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2538527

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
21.12.2022
Impfdatum
03.12.2022
Beginn
03.12.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE; an expired dose of PNEUMOVAX 23; This spontaneous report was received from a pharmacist and refers to a patient of an unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 03-DEC-2022, the patient was vaccinated with an expired dose pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection (lot #U010533, expiration date: 29-OCT-2022) administered for prophylaxis (strength, and route of administration were not provided) (Expired product administered). No additional information was provided to further clarify any details. No additional adverse event (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2527253

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

gering
Staat
ID
Alter
-
Geschlecht
U
Eingang
09.12.2022
Impfdatum
31.10.2022
Beginn
31.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

No additional AE; PNEUMOVAX 23 was administered after the expiry date. Caller did not provide the date administered, the lot or date of expiration; This spontaneous report has been received from a pharmacist referring to a patient of unknown age and gender. The patient's pertinent medical history, drugs reactions or allergies and concomitant medications were not provided. On 31-OCT-2022, the patient was vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX 23) syringe piston, lot number U010533 has been verified to be a valid lot number with expiration date on 29-OCT-2022, administered as prophylaxis (strength, dose, frequency, route of administration and anatomical location was not provided). There was no previous temperature excursion. No additional adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2524795

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

gering
Staat
AZ
Alter
-
Geschlecht
U
Eingang
07.12.2022
Impfdatum
08.11.2022
Beginn
08.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AEs; an expired dose of PNEUMOVAX 23 was administered on 11/08/2022; This spontaneous report was received from a pharmacy technician and refers to a patient of unknown gender and age. There was no information about the patient's pertinent medical history, concomitant medications or drug reactions and allergies. On 08-NOV-2022, the patient was vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX 23) prefilled syringe, injection, lot U010533, expiration date 29-OCT-2022 (exact dose, route of administration and anatomical location were not reported) for prophylaxis (Expired product administered). No additional adverse events were reported (No adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2523562

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

gering
Staat
MO
Alter
-
Geschlecht
F
Eingang
06.12.2022
Impfdatum
03.11.2022
Beginn
03.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE reported; Pharmacist reports the administration of an expired dose of PNEUMOVAX 23 [ Lot: U010533; Exp:10/29/2022] to a patient on 03NOV2022.; This non-valid spontaneous report was received from a pharmacist, referring to an unspecified patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, previous drug reactions, or allergies were not reported. On 03-NOV-2022, the patient was vaccinated with and expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (strength, vaccination scheme, anatomical site of vaccination and route of administration were not reported; lot number U010533, expiration date reported and validated as 29-OCT-2022) as prophylaxis (expired product administered). No additional adverse event reported (no adverse event). Caller confirmed vaccine was not involved in a temperature excursion and was stored in the recommended storage range until administration. This case was considered non-valid due to the lack of patient's identifiers. Follow up information has been received from the pharmacist on 01-DEC-2022. The patient was a female. This follow up made the case valid due to providing patient's identifier.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2499593

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge u010533

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
04.11.2022
Impfdatum
01.11.2022
Beginn
01.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

Confirmed with caller no other AE occurred; The caller said an expired dose was administered on 11/1/2022; This spontaneous report was received from a pharmacist and refers to a patient of unknown gender and age. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 01-NOV-2022, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23)syringe, injection, 1 dose, lot number u010533, expiration date: 29-OCT-2022, administered for prophylaxis (exact dose, strength, and route of administration were not provided) (expired product administered. No other adverse event occurred (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2422682

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

gering
Staat
-
Alter
69,0
Geschlecht
F
Eingang
29.08.2022
Impfdatum
26.08.2022
Beginn
27.08.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Erythema Peripheral swelling

Symptomtext

Swollen red arm

Weitere VAERSDATA-Felder
Praegender Schweregrund
Erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2401029

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

gering
Staat
PA
Alter
-
Geschlecht
U
Eingang
04.08.2022
Impfdatum
14.06.2022
Beginn
14.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Wrong product administered

Symptomtext

the patient did not experience any side effects or adverse events from the PNEUMOVAX 23.; Medical assistant calling in to report an AE for a patient. Per caller patient received a dose of PNEUMOVAX 23 on 14JUN22022 instead of PREVNAR 13. Caller states that the patient did not experience any side effects or adverse events from the PNEUMOVA; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not provided. On 14-JUN-2022, the patient was vaccinated with a dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) 0.5 milliliter intramuscularly, lot # U010533, expiration date 29-OCT-2022 for prophylaxis; instead of the intended dose of pneumococcal vaccine conj 13v (crm197) (PREVNAR 13) (wrong product administered). The patient did not experience any side effects or adverse events from the administered vaccine (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2233947

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

gering
Staat
SC
Alter
65,0
Geschlecht
M
Eingang
14.04.2022
Impfdatum
12.04.2022
Beginn
12.04.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Hypersensitivity Peripheral swelling

Symptomtext

PATIENT EXPERIENCE ALLERGIC REACTION RESULTING IN SEVERE SWELLING AND REDNESS UNDERNEATH UPPER LEFT ARM

Weitere VAERSDATA-Felder
Praegender Schweregrund
Erythema
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
HEART DISEASE
Vorgeschichte
HEART DISEASE
Andere Medikamente
METOPROLOL ER 25MG, ENALAPRIL 2.5, CRESTOR 40, PRASUGREL 10MG
Allergien
NO ALLERGIES ON FILE
Vorherige Impfungen
-

VAERS 2210214

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

gering
Staat
KS
Alter
67,0
Geschlecht
F
Eingang
31.03.2022
Impfdatum
28.12.2021
Beginn
28.12.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered

Symptomtext

On 3/31/22 it was discovered that the patient has received two doses of Pneumovax 23. One dose was given on 12/5/20 and the other dose was given on 12/28/21. I have tried to reach out to the patient but the phone number says voicemail has not been set up. As far as we know there were no adverse events for receiving the same vaccine twice. We will update when we talk to the patient.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
NKA
Vorherige Impfungen
-

VAERS 2210015

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

gering
Staat
KS
Alter
67,0
Geschlecht
M
Eingang
31.03.2022
Impfdatum
28.12.2021
Beginn
28.12.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Inappropriate schedule of product administration No adverse event

Symptomtext

On 3/31/22 it was discovered that the patient has received two doses of Pneumovax 23. One dose was given on 12/5/20 and the other dose was given on 12/28/21. I have tried to reach out to the patient and had to leave a message. As far as we know there were no adverse events for receiving the same vaccine twice. We will update when we talk to the patient.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
na
Aktuelle Erkrankungen
na
Vorgeschichte
no known
Andere Medikamente
unknown
Allergien
NKA
Vorherige Impfungen
-

VAERS 2032161

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

gering
Staat
MI
Alter
-
Geschlecht
F
Eingang
13.01.2022
Impfdatum
01.06.2020
Beginn
13.01.2022
Tage bis Beginn
591,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration No adverse event Wrong product administered

Symptomtext

No additional AE reported; they accidentally administered a second dose of PNEUMOV AX 23 today; This spontaneous report has been received from a medical assistant (MA) and refers to a female patient of unknown age. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not provided. On an unknown date in June 2020, the patient received her first dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (dose, route of administration, vaccine scheme, lot number, expiration date were not provided). On 13-JAN-2022 (reported as: today), the was accidentally vaccinated with the second dose of the vaccine 0.5 milliliter, once (route of administration and vaccine scheme were not provided; lot number U010533 has been verified to be a valid lot number; expiration date reported and established as: 29-OCT-2022), both as prophylaxis (inappropriate schedule of product administration). No additional adverse events reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2032161

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

gering
Staat
MI
Alter
-
Geschlecht
F
Eingang
13.01.2022
Impfdatum
01.06.2020
Beginn
13.01.2022
Tage bis Beginn
591,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration No adverse event Wrong product administered

Symptomtext

No additional AE reported; they accidentally administered a second dose of PNEUMOV AX 23 today; This spontaneous report has been received from a medical assistant (MA) and refers to a female patient of unknown age. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not provided. On an unknown date in June 2020, the patient received her first dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (dose, route of administration, vaccine scheme, lot number, expiration date were not provided). On 13-JAN-2022 (reported as: today), the was accidentally vaccinated with the second dose of the vaccine 0.5 milliliter, once (route of administration and vaccine scheme were not provided; lot number U010533 has been verified to be a valid lot number; expiration date reported and established as: 29-OCT-2022), both as prophylaxis (inappropriate schedule of product administration). No additional adverse events reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1998418

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

gering
Staat
OK
Alter
-
Geschlecht
M
Eingang
03.01.2022
Impfdatum
21.12.2021
Beginn
21.12.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental exposure to product Occupational exposure to product

Symptomtext

He also stated that some were splashed onto his skin on his hand; it leaked from the needle due to human error during the administration. He also stated that some were splashed onto his skin on his hand; This spontaneous report was received from a male pharmacist (patient of unknown age) referring to himself. The patient's concomitant medication, pertinent medical history and drug reactions/ allergies were not reported. On 21-DEC-2021, the pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot # U010533, expiration date 29-OCT-2022; strength, dose and route were not reported) was vaccinated to another patient (another linked case) for prophylaxis, some were splashed onto this patient (the pharmacist) skin on his hand (Accidental exposure to product, Occupational exposure to product). This is one of two reports received from the same reporter. ; Sender's Comments: US-009507513-2112USA008400:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental exposure to product
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1998417

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

gering
Staat
OK
Alter
-
Geschlecht
U
Eingang
03.01.2022
Impfdatum
21.12.2021
Beginn
21.12.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered Needle issue

Symptomtext

No additional AEs were reported; a patient received less than the recommended dose; it leaked from the needle due to human error; This spontaneous report was received from a pharmacist referring to a patient of unknown age. The patient's concomitant medication, pertinent medical history and drug reactions/ allergies were not reported. On 21-DEC-2021 the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot # U010533, expiration date 29-OCT-2022; strength, dose and route were not reported) for prophylaxis, which was less than the recommended dose because it leaked from the needle due to human error during the administration (accidental underdose, needle issue). The pharmacist also stated that some were splashed onto his (pharmacist) skin on his hand (split as another case). No additional AEs were reported. This is one of two reports received from the same reporter. ; Sender's Comments: US-009507513-2112USA009520:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1916587

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

gering
Staat
NC
Alter
34,0
Geschlecht
F
Eingang
02.12.2021
Impfdatum
23.11.2021
Beginn
23.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Ageusia Eyelid function disorder Facial paresis

Symptomtext

34yr old patient with history of obesity, generalized edema, sickle cell trait, HTN, seasonal allergies (on Flonase BID, cetirizine) and other comorbidities presented on 11/23/21 to clinic for well-visit. PA ordered Pneumococcal Polysaccharide 23-valent (Pneumovax-23) LOT # U010533, administered IM in patient's right deltoid by CMA. On 11/26, patient presented at OSH with right sided facial weakness. Symptoms started same day with loss of taste on right side of tongue, inability to close right eye. Patient not started on prednisone at ED as per patient "provider could not see her medical history in system". Patient seen by PA on 11/29 and prescribed Prednisone taper [576853217]. Pneumococcal vaccine added to allergy list.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Ageusia
Hospital-Tage
-
Labordaten
unknown
Aktuelle Erkrankungen
vaginal infection
Vorgeschichte
unknown
Andere Medikamente
flonase BID, cetirizine, chorionicgonadotropin alfa, fluoxetin
Allergien
tramadol (dizziness), gardasil (vomitting)
Vorherige Impfungen
Gardasil (vomitting)--unknown when immunization given, possibly 2009? patient did not finish series

VAERS 1860043

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

gering
Staat
KS
Alter
0,5
Geschlecht
M
Eingang
11.11.2021
Impfdatum
28.10.2021
Beginn
28.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; she accidentally admnistered PNEUMOVAX 23 to a 6 months old instead of PREVNAR 13; she accidentally admnistered PNEUMOVAX 23 to a 6 months old instead of PREVNAR 13; This spontaneous report was received from a nurse and refers to a 6 month old male patient. The patient's current conditions, pertinent medical history, drug reactions or allergies, and concomitant therapies were not reported. The nurse reported that on 28-OCT-2021, she accidently administered pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) lot number U010533 with expiration date 29-OCT-2022 (dosage, route of administration and anatomical location were not reported) for prophylaxis, to the patient instead of the third dose of pneumococcal vaccine conj 13v (crm197) (PREVNAR 13) (Wrong product administered and product use issue). No additional adverse event (AE) reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1836772

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

gering
Staat
NC
Alter
1,5
Geschlecht
F
Eingang
02.11.2021
Impfdatum
01.11.2021
Beginn
01.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age Wrong product administered

Symptomtext

Patient was given a Pneumococcal 23 and should have been given Prevnar 13. At this time, the patient's mom has not reported any problems.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 1828388

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

gering
Staat
TX
Alter
67,0
Geschlecht
M
Eingang
29.10.2021
Impfdatum
20.10.2021
Beginn
21.10.2021
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema

Symptomtext

The patient developed erythema 4 to 6 inches below the injection site of PNEUMOVAX 23; This spontaneous report was received from a pharmacist concerning a 67-year-old male patient. Pertinent medical history and concomitant therapy was unknown. There were no drug reactions/ allergies. On 20-OCT-2021, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) (lot # U010533, expiration date reported and confirm upon internal validation; strength was unknown) 0.5 mL, once, intramuscularly for vaccination. On 21-OCT-2021, the patient developed erythema 4 to 6 inches below the injection site of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23). The patient saw the pharmacist. The treatment was not given for the events. No lab diagnostics/studies was performed. The outcome of erythema was reported as recovering/resolving. The causality assessment was not provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1768819

MERCK & CO. INC. · PNEUMO (PNEUMOVAX) · Charge U010533

gering
Staat
IL
Alter
96,0
Geschlecht
M
Eingang
07.10.2021
Impfdatum
05.10.2021
Beginn
05.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Asthenia Unresponsive to stimuli Vaccination complication

Symptomtext

PATIENT HAD ADVERSE REACTION TO PNEUMOVAX 23 AND FLUZONE HD VACCINE; FOUND UNRESPONSIVE IN ROOM APPROXIMATELY 11 HOURS LATER; EMS NOTIFIED AND PATIENT TRANSFERRED TO HOSPITAL FOR WEAKNESS DUE TO VACCINE ADMINISTRATION.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Asthenia
Hospital-Tage
2,0
Labordaten
UNKNOWN
Aktuelle Erkrankungen
PATIENT REPORTED FEELING WELL ON CONSENT FORM
Vorgeschichte
DIABETES
Andere Medikamente
UNKNOWN; NOT INDICATED ON VACCINATION CONSENT FORM
Allergien
NO ALLERGIES TO FOOD, MEDICATIONS, PET OR ENVIRONMENTAL ALLERGIES INDICATED ON CONSENT FORM.
Vorherige Impfungen
-